Keywords: cephalon, initiate, gabitril, phase, iii, program, second

Cephalon to initiate Gabitril Phase III program in second half of 2004

Article | 19 April 2004

Print This

Cephalon of the USA plans to initiate Phase III clinical studies of Gabitril (tiagabine hydrochloride) for the treatment of anxiety ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in